Anticoagulants in atrial fibrillation patients with chronic kidney disease
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anticoagulants in atrial fibrillation patients with chronic kidney disease
Authors
Keywords
-
Journal
Nature Reviews Nephrology
Volume 8, Issue 10, Pages 569-578
Publisher
Springer Nature
Online
2012-07-24
DOI
10.1038/nrneph.2012.160
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors
- (2012) Scott Kaatz et al. AMERICAN JOURNAL OF HEMATOLOGY
- Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding
- (2012) T. E. Warkentin et al. BLOOD
- Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control
- (2012) Allan C. Skanes et al. CANADIAN JOURNAL OF CARDIOLOGY
- Newer Oral Anticoagulants Should Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation and Risk Factors for Stroke or Thromboembolism
- (2012) Christopher B. Granger et al. CIRCULATION
- New Oral Anticoagulants Should Not Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation
- (2012) Jack Ansell CIRCULATION
- Bleeding Risk with Dabigatran in the Frail Elderly
- (2012) Paul Harper et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran
- (2012) Robert G. Hart et al. STROKE
- Chronic Kidney Disease and CHADS2 Score Independently Predict Cardiovascular Events and Mortality in Patients With Nonvalvular Atrial Fibrillation
- (2011) Keiko Nakagawa et al. AMERICAN JOURNAL OF CARDIOLOGY
- Risk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rules
- (2011) Peter Loewen et al. ANNALS OF HEMATOLOGY
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
- (2011) John W. Eikelboom et al. CIRCULATION
- Effectiveness and Safety of Warfarin Initiation in Older Hemodialysis Patients with Incident Atrial Fibrillation
- (2011) W. C. Winkelmayer et al. Clinical Journal of the American Society of Nephrology
- Warfarin in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease
- (2011) R. G. Hart et al. Clinical Journal of the American Society of Nephrology
- Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
- (2011) K. A. A. Fox et al. EUROPEAN HEART JOURNAL
- Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation
- (2011) Ricarda Marinigh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A New Risk Scheme to Predict Warfarin-Associated Hemorrhage
- (2011) Margaret C. Fang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
- (2011) Charles A. Herzog et al. KIDNEY INTERNATIONAL
- The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients
- (2011) James B. Wetmore et al. KIDNEY INTERNATIONAL
- Chronic kidney disease
- (2011) Andrew S Levey et al. LANCET
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)
- (2010) Christian T. Ruff et al. AMERICAN HEART JOURNAL
- Chronic kidney disease and prevalent atrial fibrillation: The Chronic Renal Insufficiency Cohort (CRIC)
- (2010) Elsayed Z. Soliman et al. AMERICAN HEART JOURNAL
- New Anticoagulants
- (2010) John W. Eikelboom et al. CIRCULATION
- Association of Chronic Kidney Disease With Atrial Fibrillation Among Adults in the United States
- (2010) Usman Baber et al. Circulation-Arrhythmia and Electrophysiology
- Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate
- (2010) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- Warfarin in haemodialysis patients with atrial fibrillation: what benefit?
- (2010) F. Yang et al. EUROPACE
- Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation
- (2010) Gregory Y.H. Lip et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy
- (2010) Volker Wizemann et al. KIDNEY INTERNATIONAL
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
- (2010) Joachim Stangier et al. THROMBOSIS AND HAEMOSTASIS
- Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation
- (2009) Alan S. Go et al. CIRCULATION
- Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial Fibrillation
- (2009) K. E. Chan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Anticoagulant and Antiplatelet Usage Associates with Mortality among Hemodialysis Patients
- (2009) K. E. Chan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Kidney Function Influences Warfarin Responsiveness and Hemorrhagic Complications
- (2009) N. A. Limdi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Outcome of atrial fibrillation among patients with end-stage renal disease
- (2009) C. Y. Chou et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Atrial Fibrillation and Morbidity and Mortality in a Cohort of Long-term Hemodialysis Patients
- (2008) Simonetta Genovesi et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range
- (2008) Stuart J. Connolly et al. CIRCULATION
- Warfarin for atrial fibrillation in community-based practise
- (2008) A. J. ROSE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Major Bleeding in Hemodialysis Patients
- (2007) R. M. Holden et al. Clinical Journal of the American Society of Nephrology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started